Breast Cancer

Anthracycline chemotherapy for breast cancer treatment may not cause decline in cognitive function.

The PI3K/AKT pathway may provide a new therapeutic target for breast cancer combination therapy.

Treatment approach may eradicate triple-negative breast cancer.

Cancer diagnosis may potentially cause a decrease in physical function and mental health.

Cisplatin kills both rapidly dividing cells and non-dividing cells in the inner ear, which can lead to hearing loss.

Epigenetic changes can leave cancer stem cells vulnerable to a combination of 5-azacytidine and butyrate.

Targaprimir-96 causes programmed cell death in breast cancer animal models.

Top news of the day from across the health care landscape.

Blocking estrogen production by using an aromatase inhibitor stopped seizures in animal models.

Patients taking mitoxantrone for multiple sclerosis found to have higher rates of breast and colorectal cancers and leukemia.

Patients administered mitoxantrone for multiple sclerosis carry higher rates of breast and colorectal cancers and leukemia.

The small molecule drug, SI-2, found to improve cancer treatment in mouse models.

Women with proliferating cells within mammary epithelium cells significantly more likely to develop breast cancer.

Infertility and breast density may impact the risk of cancer.

Infertility and breast density may impact the risk of cancer.

JAK2 could potentially cause treatment resistance in TNBC.

JAK2 could potentially cause treatment resistance in TNBC.

Treatment costs climb with advanced-stage breast cancer compared with earlier stages.

Neratinib plus paclitaxel did not improve outcomes in metastatic ERBB2-positive breast cancer.

Mevalonate pathway associated with cell-signaling protein that promotes breast cancer development.

Blue-green algae discovered in Panama carries potent anti-cancer activity.

Pfizer announced Ibrance met its primary endpoint in postmenopausal women with human epidermal growth factor receptor 2-negative (ER+, HER2-) advanced or metastatic breast cancer.

Pfizer announced Ibrance met its primary endpoint in postmenopausal women with human epidermal growth factor receptor 2-negative (ER+, HER2-) advanced or metastatic breast cancer.

Bisphenol A is found in numerous plastic and resin household products.

Individualized approach allows for creation of widespread models of patient-specific tumors.

Recurrence Score test may help some women with breast cancer be spared of chemotherapy without experiencing disease progression.

Evista is typically given to women after menopause to treat and prevent osteoporosis and reduce the risk of invasive breast cancer.

New treatment approach offers less severe side effects from chemotherapy.

Study finds incidence of post-traumatic stress symptoms in breast cancer patients to be underestimated.

Alcohol can affect estrogen in breast cancer cells and weakens the ability of drugs that halt proliferation.